As of 2024-12-15, the EV/EBITDA ratio of MaxCyte Inc (MXCT.L) is -14.71. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MXCT.L's latest enterprise value is 233.28 mil GBP. MXCT.L's TTM EBITDA according to its financial statements is -15.86 mil GBP. Dividing these 2 quantities gives us the above MXCT.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.2x - 16.1x | 15.2x |
| Forward P/E multiples | 15.3x - 16.5x | 15.6x |
| Fair Price | (172.25) - (183.55) | (173.73) |
| Upside | -151.6% - -155.0% | -152.0% |
| Date | EV/EBITDA |
| 2024-12-13 | -18.64 |
| 2024-12-12 | -18.59 |
| 2024-12-11 | -17.86 |
| 2024-12-10 | -17.86 |
| 2024-12-09 | -17.26 |
| 2024-12-06 | -14.86 |
| 2024-12-05 | -15.00 |
| 2024-12-04 | -15.00 |
| 2024-12-03 | -14.80 |
| 2024-12-02 | -14.73 |
| 2024-11-29 | -14.60 |
| 2024-11-28 | -14.60 |
| 2024-11-27 | -14.80 |
| 2024-11-26 | -14.40 |
| 2024-11-25 | -15.26 |
| 2024-11-22 | -14.33 |
| 2024-11-21 | -14.00 |
| 2024-11-20 | -13.73 |
| 2024-11-19 | -13.73 |
| 2024-11-18 | -14.06 |
| 2024-11-15 | -14.60 |
| 2024-11-14 | -14.60 |
| 2024-11-13 | -14.26 |
| 2024-11-12 | -14.60 |
| 2024-11-11 | -13.73 |
| 2024-11-08 | -14.33 |
| 2024-11-07 | -14.86 |
| 2024-11-06 | -16.46 |
| 2024-11-05 | -15.53 |
| 2024-11-04 | -15.46 |
| 2024-11-01 | -15.13 |
| 2024-10-31 | -14.86 |
| 2024-10-30 | -14.60 |
| 2024-10-29 | -14.60 |
| 2024-10-28 | -15.26 |
| 2024-10-25 | -15.66 |
| 2024-10-24 | -15.66 |
| 2024-10-23 | -15.66 |
| 2024-10-22 | -15.66 |
| 2024-10-21 | -15.66 |
| 2024-10-18 | -15.73 |
| 2024-10-17 | -15.73 |
| 2024-10-16 | -15.73 |
| 2024-10-15 | -15.73 |
| 2024-10-14 | -15.93 |
| 2024-10-11 | -15.26 |
| 2024-10-10 | -15.66 |
| 2024-10-09 | -15.13 |
| 2024-10-08 | -15.66 |
| 2024-10-07 | -15.39 |